On December 31, 2009, BioCryst Pharmaceuticals (BCRX) had a market capitalization of $283.8M, based on 43.93M shares at a price of $6.46.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 31 2009 | $6.46 | 745,284 | 43,925,000 | $283,755,500.00 |
December 30 2009 | $6.44 | 943,953 | 43,925,000 | $282,877,000.00 |
December 29 2009 | $6.47 | 833,572 | 43,925,000 | $284,194,750.00 |
December 28 2009 | $6.69 | 1,973,941 | 43,925,000 | $293,858,250.00 |
December 24 2009 | $6.83 | 2,889,970 | 43,925,000 | $300,007,750.00 |
December 23 2009 | $6.14 | 1,267,141 | 43,925,000 | $269,699,500.00 |
December 22 2009 | $6.02 | 1,346,226 | 43,925,000 | $264,428,500.00 |
December 21 2009 | $5.88 | 1,137,202 | 43,925,000 | $258,279,000.00 |
December 18 2009 | $5.91 | 1,957,303 | 43,925,000 | $259,596,750.00 |
December 17 2009 | $6.16 | 2,115,671 | 43,925,000 | $270,578,000.00 |
December 16 2009 | $6.63 | 917,079 | 43,925,000 | $291,222,750.00 |
December 15 2009 | $6.77 | 1,764,880 | 43,925,000 | $297,372,250.00 |
December 14 2009 | $6.65 | 972,937 | 43,925,000 | $292,101,250.00 |
December 11 2009 | $6.70 | 1,130,310 | 43,925,000 | $294,297,500.00 |
December 10 2009 | $6.83 | 1,205,355 | 43,925,000 | $300,007,750.00 |
December 09 2009 | $7.03 | 2,302,548 | 43,925,000 | $308,792,750.00 |
December 08 2009 | $6.70 | 2,725,922 | 43,925,000 | $294,297,500.00 |
December 07 2009 | $7.05 | 3,343,297 | 43,925,000 | $309,671,250.00 |
December 04 2009 | $7.57 | 2,581,514 | 43,925,000 | $332,512,250.00 |
December 03 2009 | $7.81 | 1,509,374 | 43,925,000 | $343,054,250.00 |
December 02 2009 | $8.15 | 1,480,210 | 43,925,000 | $357,988,750.00 |
December 01 2009 | $8.28 | 2,718,273 | 43,925,000 | $363,699,000.00 |
November 30 2009 | $8.11 | 1,903,240 | 43,925,000 | $356,231,750.00 |
November 27 2009 | $8.16 | 1,220,067 | 43,925,000 | $358,428,000.00 |
November 25 2009 | $8.67 | 1,398,089 | 43,925,000 | $380,829,750.00 |
